Screening for germ‐line mutations in the NF2 Gene

Genes, Chromosomes and Cancer

Volumn 12, Issue 2, 1995, Pages 117-127

  Mérel, Philippe ^a   Hoang‐Xuan, Khé ^a   Sanson, Marc ^a   Bijlsma, Emilia ^b   Rouleau, Guy ^c   Laurent‐Puig, Pierre ^a   Pulst, Stephan ^d   Baser, Michael ^d   Lenoir, Gilbert ^e   Sterkers, Jean Marc ^f   Philippon, Jacques ^g   Resche, François ^h   Mautner, Victor F ⁱ   Fischer, Georges ^j   Hulsebos, Theo ^b   Aurias, Alain ^a   Delattre, Olivier ^a   Thomas, Gilles ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f Clinique Bachaumont   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h NANTES UNIVERSITY HOSPITAL   (France)

ⁱ Neurological Department   (Germany)

^j UNIVERSITÉ DE LYON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; ARTICLE; CANCER INHIBITION; CHROMOSOME 22; DISEASE PREDISPOSITION; GENE LOCATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENINGIOMA; NEURILEMOMA; NEUROFIBROMATOSIS; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD;

BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, NEUROFIBROMATOSIS 2; GENOTYPE; GERM-LINE MUTATION; HUMAN; MOLECULAR SEQUENCE DATA; PHENOTYPE; POINT MUTATION;

EID: 0028837397     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.2870120206     Document Type: Article

References (30)

1. Comprehensive detection of single base changes in human genomic DNA using denaturing gradient gel electrophoresis and a GC clamp
2. Wizardry at the cell cortex
3. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane‐cytoskeletal linker
4. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumor types
5. Germ‐line mutations in the neurofibromatosis type 2 tumour suppressor gene
6. A mutation in the neurofibromatosis type 2 tumor‐suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals
7. A genetic study of type‐2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity
8. A genetic study of type‐2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling
9. DNA fragments differing by single base‐pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory
10. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors
11. Exon scanning for mutation of the NF2 gene in schwannomas
12. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas
13. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis
14. Cytoskeleton‐plasma membrane interactions
15. DNA diagnosis of neurofibromatosis 2
16. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis)
17. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene
18. Nearly all single base substitutions in DNA fragments joined to a GC‐clamp can be detected by denaturing gradient gel electrophoresis
19. Neurofibromatosis type 2 appears to be a genetically homogeneous disease
20. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22
21. Alteration in a new gene encoding a putative membrane‐organizing protein causes neurofibromatosis type 2
22. Germ‐line deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus
23. A gene family consisting of ezrin, radixin and moesin
24. Attachment of a 40‐base‐pair G+C‐rich sequence (GC‐clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single‐base changes
25. A novel moesin‐, ezrin‐, radixin‐like gene is a candidate for the neurofibromatosis 2 tumor suppressor
26. The neurofibromatosis type 2 gene is inactivated in schwannomas
27. The neurofibromatosis type 1 gene
28. Structural basis for the binding of proline‐rich peptides to SH3 domains